Target intelligence / Profile preview

Nck-associated protein 1-like (NCKAP1L)

Target
NCKAP1L
Molecular classification
Cytoplasmic adaptor protein, Member of the WAVE regulatory complex (Scar/WAVE complex), Actin cytoskeleton regulator, Other (Nap family protein — Nap1-like)
01

Overview

Nck-associated protein 1-like (NCKAP1L) is a hematopoietic-specific, highly conserved cytoplasmic protein that is a critical component of the WAVE regulatory complex, responsible for actin cytoskeleton organization. It is selectively expressed in hematopoietic cells, where it regulates lymphocyte development, activation, proliferation, immune synapse formation, neutrophil and macrophage migration, and phagocytic cup formation. NCKAP1L operates downstream of Rac1 and Cdk5 to stimulate F-actin polymerization in response to immune receptor and cytokine signaling. Importantly, biallelic mutations in NCKAP1L cause immunodeficiency with autoinflammation and lymphoproliferation; this clinical syndrome is marked by defective immune activation, early T cell exhaustion, impaired migration and phagocytosis, and features of actinopathies. In animal research, a minor isoform of NCKAP1L also regulates intrahepatic biliary network formation, indicating specialized roles beyond the immune system.

Other names
Hematopoietic protein 1Membrane-associated protein HEM-1HEM1IMD72Nck-associated protein 1-likeMembrane-associated protein hem-1NCKPL
02

Mechanism of action

Not established for direct pharmacological targeting. Rac1 inhibitors and Cdk5 pathway modulators may negatively influence NCKAP1L-dependent processes by interfering with actin polymerization. Any drug affecting actin cytoskeletal regulation could theoretically influence NCKAP1L-related pathways.

03

Biological functions

Regulation of actin cytoskeletonCell shape organizationLymphocyte development and activationImmune synapse formationNeutrophil migrationPhagocytosisCell proliferationCell migrationCytokine secretion (including IL2, TNF)Homeostasis in hematopoietic cellsBiliary network morphogenesis (“short isoform” in biliary epithelial cells)Signal transduction downstream of Rac1 and Cdk5
04

Disease associations

Primary immunodeficiency (“Immunodeficiency 72 with autoinflammation and lymphoproliferation”)Hyperinflammatory syndromes (features of hemophagocytic lymphohistiocytosis)Lymphoproliferative disordersDefects in immune responseActinopathiesCholestatic liver disease (in zebrafish model via intrahepatic biliary network defects)
05

Safety considerations

Genetic deficiency causes broad immune dysregulation, risk of infection, autoimmunity, lymphoproliferation, and hyperinflammationPotential concerns with drugs interfering in cytoskeleton regulation (off-target immune, hematopoietic, and liver toxicity)
06

Interacting drugs

No specific drugs directly targeting NCKAP1L

2 more in the full profile.

07

Biomarkers

NCKAP1L mutations are associated with immunodeficiency 72 (IMD72) and associated inflammatory and lymphoproliferative statesT cell exhaustion signature (immunophenotyping: inverted CD4/CD8 ratio and memory compartment shift) for diagnosis and monitoring of NCKAP1L deficiencyPhagocytic and lymphocyte migration defects could serve as functional biomarkers in research context

Beyond the preview

Go deeper on Nck-associated protein 1-like (NCKAP1L).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nck-associated protein 1-like (NCKAP1L).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call